Harvard Bioscience, Inc. (HBIO)

NASDAQ: HBIO · Real-Time Price · USD

0.990

-0.190 (-16.10%)

At close: Feb 21, 2025, 4:00 PM

1.020

+0.030 (3.03%)

After-hours: Feb 21, 2025, 6:28 PM EST

Harvard Bioscience Market Cap

Harvard Bioscience has a market cap or net worth of $43.17 million as of February 21, 2025. Its market cap has decreased by -78.39% in one year.

Market Cap

43.17M

Enterprise Value

84.52M

1-Year Change

-78.39%

Ranking

#4539

Market Cap Chart

Since March 19, 2001, Harvard Bioscience's market cap has decreased from $173.50M to $43.17M, a decrease of -75.12%. That is a compound annual growth rate of -5.64%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	43.20M	-53.04%
Dec 31, 2024	92.00M	-59.72%
Dec 29, 2023	228.40M	97.92%
Dec 30, 2022	115.40M	-59.89%
Dec 31, 2021	287.70M	72.07%
Dec 31, 2020	167.20M	44.01%
Dec 31, 2019	116.10M	-2.11%
Dec 31, 2018	118.60M	3.04%
Dec 29, 2017	115.10M	9.83%
Dec 30, 2016	104.80M	-11.04%
Dec 31, 2015	117.80M	-35.91%
Dec 31, 2014	183.80M	26.15%
Dec 31, 2013	145.70M	15.45%
Dec 31, 2012	126.20M	14.42%
Dec 30, 2011	110.30M	-4.42%
Dec 31, 2010	115.40M	9.70%
Dec 31, 2009	105.20M	29.08%
Dec 31, 2008	81.50M	-42.24%
Dec 31, 2007	141.10M	-9.96%
Dec 29, 2006	156.70M	15.56%
Dec 30, 2005	135.60M	-3.49%
Dec 31, 2004	140.50M	-47.56%
Dec 31, 2003	267.90M	170.88%
Dec 31, 2002	98.90M	-62.67%
Dec 31, 2001	264.90M	52.68%

View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B

Market Cap Rankings